AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇷🇼

BILASTINE in Rwanda

2 products registered with RDA 2 active

Brand / ProductReg. No.HolderStatusExpires
ALERBIX
ORAL SOLUTION
Rwanda FDA-HMP-MA-2213FAES FARMA, S.Aactive3 Feb 2030
BILAXTEN
Tablets
Rwanda FDA-HMP-MA-1761FAES FARMA, S.A.active16 Aug 2029

BILASTINERDA Registration Details

RDA (Rwanda) has 2 registered products containing BILASTINE, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.

Track BILASTINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.